Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 6.52B 964M 846M 787M 724M 1.36B 92.05B 1.38B 9.34B 3.66B 45.65B 3.62B 3.54B 158B P/E 2026 *
12.2x
P/E 2027 * 10.2x
Enterprise Value 5.18B 766M 672M 626M 575M 1.08B 73.15B 1.1B 7.42B 2.91B 36.28B 2.87B 2.81B 125B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.26x
Free-Float
51.88%
Yield 2026 *
4.17%
Yield 2027 * 4.7%
1 day+0.26%
1 week-0.87%
Current month+18.46%
1 month+14.98%
3 months-8.24%
6 months-18.86%
Current year-11.66%
1 week 10.83
Extreme 10.83
11.55
1 month 9.41
Extreme 9.41
11.7
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
15.66
3 years 9.41
Extreme 9.41
26.96
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
12/5/26 Buy

Founder

1,359,000 0.3397%
12/5/26 Sell

Founder

-2,727,600 0.6818%
11/5/26 Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%-0.87%-24.37%-55.17% 961M
+0.48%-0.84%-21.16%-31.04% 15.37B
+0.59%-0.58%-29.13%-36.48% 7.03B
+3.35%+2.27%-18.31%-6.32% 6.02B
+1.49%+4.37%-8.06%-28.67% 3.96B
+0.86%+4.44%-27.36%-46.89% 3.23B
+1.24%+0.11%+9.60%-32.83% 3.13B
+1.14%-5.95%-41.24%-23.21% 3B
+1.31%+4.16%-12.08%+6.26% 2.66B
+0.96%+5.23%+103.70% - 2.63B
Average +1.17%+1.25%-6.84%-28.26% 4.8B
Weighted average by Cap. +1.12%+0.69%-13.28%-27.45%

Financials

2026 *2027 *
Net sales 18.05B 2.67B 2.34B 2.18B 2B 3.76B 255B 3.82B 25.85B 10.12B 126B 10.01B 9.79B 436B 19.16B 2.83B 2.48B 2.31B 2.13B 3.99B 270B 4.06B 27.44B 10.74B 134B 10.63B 10.4B 463B
Net income 545M 80.53M 70.68M 65.81M 60.53M 113M 7.69B 115M 781M 306M 3.82B 302M 296M 13.18B 650M 95.98M 84.23M 78.44M 72.14M 135M 9.17B 138M 931M 364M 4.55B 360M 353M 15.71B
Net Debt -1.34B -198M -174M -162M -149M -279M -18.91B -284M -1.92B -751M -9.38B -743M -727M -32.4B -1.63B -241M -211M -197M -181M -339M -23.01B -345M -2.34B -914M -11.41B -904M -885M -39.43B
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
28/07/26 CNY 11.36 +0.26% 7,599,300
27/07/26 CNY 11.33 +3.47% 15,936,676
24/07/26 CNY 10.95 -3.10% 6,603,692
23/07/26 CNY 11.30 -0.70% 6,615,610
22/07/26 CNY 11.38 +0.71% 13,145,803
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.36CNY
Average target price
14.86CNY
Spread / Average Target
+30.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock